Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Genetic Technologies Ltd
Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
July 16, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType to Enter Canadian and New Zealand Markets
July 09, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
June 25, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
June 21, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Expands Operational Capacity in North America
June 18, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
June 05, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
May 29, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType and Humanise Health host “Know Your Risk” Event
May 23, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
May 06, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Appendix 4C & Quarterly Business Update – March 2024
April 30, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
April 22, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Announces $2 Million Registered Direct Offering
April 18, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
April 17, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
April 16, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG to pilot GeneType in Breast Screen centers across the U.S.
April 11, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
April 08, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
April 02, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG Global Collaborations and Innovation Update
March 26, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
March 25, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG to launch U.S. Customer Digital Media Sales Campaign
February 28, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Launching our most comprehensive test and expanding into new global markets
January 31, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
January 05, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
December 14, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
December 12, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
October 30, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
October 18, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
September 27, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
September 12, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner
September 11, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
September 01, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.